Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract

Cancers of the anogenital tract as well as some head and neck cancers are caused by persistent infections with high-risk type human papillomaviruses (HPVs). Two viral oncogenes, E6 and E7, induce severe chromosomal instability associated with centrosome aberrations, anaphase bridges, chromosome lagging, and breaking. This occurs early in preneoplastic lesions, when the viral genome still persists in an episomal state. In most invasive cancers and also in a few high-grade dysplastic lesions, however, integration of high-risk HPV genomes into the host genome is observed. Integration seems to be a direct consequence of chromosomal instability and an important molecular event in the progression of preneoplastic lesions. Disruption or deregulation of defined critical cellular gene functions by insertional mutagenesis by integrated HPV genome fragments has been hypothesized as one major promoting factor in the pathogenesis of HPV-associated cancers. This hypothesis was based on the detection of HPV integration events in the area of tumor-relevant genes in few cases. Here, we reviewed >190 reported integration loci with respect to changes in the viral structure and the targeted genomic locus. This analysis confirms that HPV integration sites are randomly distributed over the whole genome with a clear predilection for genomic fragile sites. No evidence for targeted disruption or functional alteration of critical cellular genes by the integrated viral sequences could be found.

[1]  M. Mravunac,et al.  Transition of high‐grade cervical intraepithelial neoplasia to micro‐invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities , 2004, The Journal of pathology.

[2]  A. Mincheva,et al.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization , 1987, Medical Microbiology and Immunology.

[3]  M. Kizaki,et al.  In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  David I. Smith,et al.  Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma , 2003, Oncogene.

[5]  A. Hengstermann,et al.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells , 2003, Oncogene.

[6]  M. Hoeckel,et al.  A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques , 2003, Oncogene.

[7]  B. McMahon,et al.  Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers , 2003, Oncogene.

[8]  K. Alexander,et al.  RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells , 2003, Journal of Virology.

[9]  R. Daniel,et al.  Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  David I. Smith,et al.  Common fragile sites are preferential targets for HPV16 integrations in cervical tumors , 2003, Oncogene.

[11]  M. Schwab,et al.  Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line. , 2003, Cancer letters.

[12]  K. Münger,et al.  The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. , 2002, Cancer research.

[13]  S. Syrjänen,et al.  Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. , 2002, Carcinogenesis.

[14]  F. Bosch,et al.  Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.

[15]  M. Van Ranst,et al.  Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  S. Vinokurova,et al.  Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions , 2002, Oncogene.

[17]  J. McDougall,et al.  Small Tumor Virus Genomes Are Integrated near Nuclear Matrix Attachment Regions in Transformed Cells , 2001, Journal of Virology.

[18]  Karl Münger,et al.  Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.

[19]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[20]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[21]  E. Blennow,et al.  Physical State of HPV16 and Chromosomal Mapping of the Integrated Form in Cervical Carcinomas , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[22]  K. Münger,et al.  Centrosome abnormalities, genomic instability and carcinogenic progression. , 2001, Biochimica et biophysica acta.

[23]  B. V. Van Tine,et al.  In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH. , 2001, Developments in biologicals.

[24]  E. Thorland,et al.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. , 2000, Cancer research.

[25]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[26]  J. Butel,et al.  Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. , 2000, Carcinogenesis.

[27]  M. von Knebel Doeberitz,et al.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. , 1999, Cancer research.

[28]  G. Fleuren,et al.  Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. , 1999, Cancer research.

[29]  R. Richards,et al.  Fragile sites-cytogenetic similarity with molecular diversity. , 1999, American journal of human genetics.

[30]  M. Bartelmann,et al.  APM‐1, a novel human gene, identified by aberrant co‐transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ‐zinc finger protein with growth inhibitory activity , 1998, The EMBO journal.

[31]  V. Giaché,et al.  Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. , 1997, Journal of clinical pathology.

[32]  J. Foidart,et al.  Viral integration sites in human papilloma virus-33-immortalized cervical keratinocyte cell lines. , 1996, Cancer genetics and cytogenetics.

[33]  K. Choo,et al.  Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: Frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions , 1996, Journal of medical virology.

[34]  E. Hann,et al.  Integration of human papillomavirus sequences in cervical tumor cell lines. , 1996, Annals of clinical and laboratory science.

[35]  T. Glover,et al.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. , 1996, Human molecular genetics.

[36]  G. Mukherjee,et al.  Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. , 1995, The Journal of general virology.

[37]  P. Lichter,et al.  A transcribed human sequence related to the mouse HC1 and the human papillomavirus type 18 E5 genes is located at chromosome 7p13-14. , 1995, Human molecular genetics.

[38]  X. Sastre-Garau,et al.  A recurrent human papillomavirus integration site at chromosome region 12q14-q15 in SW756 and SK-v cell lines derived from genital tumors. , 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[39]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Deisseroth,et al.  Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. , 1995, Cancer gene therapy.

[41]  A. Poustka,et al.  Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. , 1994, Cancer research.

[42]  J. McDougall,et al.  Viral integration and fragile sites in human papillomavirus‐lmmortalized human keratinocyte cell lines , 1992, Genes, chromosomes & cancer.

[43]  M. von Knebel Doeberitz,et al.  Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA , 1992, International journal of cancer.

[44]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[45]  M. Yamasaki,et al.  Chromosomal Insertion and Amplification of Human Papillomavirus 16 DNA Sequences in a Cell Line of Argyrophil Small Cell Carcinoma of the Uterine Cervix , 1991, Japanese journal of cancer research : Gann.

[46]  M. von Knebel Doeberitz,et al.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[48]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[49]  J. Settleman,et al.  Integrated HPV 1 genomes in a human keratinocyte cell line can be transactivated by a SV40/BPV1 recombinant virus which expresses BPV1 E2 proteins. , 1990, Virology.

[50]  J. DiPaolo,et al.  Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. , 1990, Cancer research.

[51]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[52]  F. Hecht,et al.  Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. , 1988, Cancer genetics and cytogenetics.

[53]  M. von Knebel Doeberitz,et al.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. , 1988, Cancer research.

[54]  C. Croce,et al.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.